Condition: Hypertriglyceridemia · Sponsor: Russian Cardiology Research and Production Center
The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagnostic approaches and treatment patterns in real-world practice. The collected data may inform future research and support improvements in patient care.
This description comes directly from the study's public registry record.
Marat Ezhov, MD, PhD · +7 495 414-6067 · Marat_Ezhov@mail.ru
Uliana Chubykina, MD, PhD · +7 495 414-6067 · uliankachubykina@gmail.com
Always discuss trial participation with your own doctor first.
| Astrakhan State Medical University | Astrakhan, Russia | Recruiting |
| Chelyabinsk State Medical Academy | Chelyabinsk, Russia | Recruiting |
| Kaluga City Clinical Hospital No. 5 | Kaluga, Russia | Recruiting |
| State Medical University | Kazan', Russia | Recruiting |
| National Medical Research Center of Cardiology Named after Academician E.I. Chazov | Moscow, Russia | Recruiting |
| Research Centre for Medical Genetics | Moscow, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07508930